We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Pharma manufacturers face a mandate from seven states and the District of Columbia to make sure their IT systems can provide a record of the gifts their sales reps have made to physicians, and the other 43 states are likely to follow within 12 to 18 months, according to a new study by Gartner.
Pharma manufacturers must make sure their IT systems can provide a record of the gifts their sales reps have made to physicians in seven states and the District of Columbia, and the other 43 states are likely to follow suit within 12 to 18 months, according to a new study by the technology research firm Gartner.
The first drug manufacturer to attach radiofrequency identification (RFID) tags to individual bottles is interested in expanding use of that technology on a popular painkiller.
A large majority of physician investigators and industry players are interested in electronic data capture (EDC) in clinical trials but uncertainty about the technology and its benefits has slowed its adoption, Clinipace Chief Scientific Officer Ronald Marks said.
It is not yet clear how much time and money electronic data capture (EDC) will save for clinical trials despite its expectations, a veteran of dozens of trials in the U.S. and Canada said.
The Heart Rhythm Society (HRS) has issued a series of recommendations for industry, the FDA and physicians to consider in revising the processes for postmarket surveillance and analysis of pacemakers and implantable cardioverter-defibrillators (ICDs).
The key to successful conversion from paper clinical trial records to electronic data capture (EDC) is in the advance preparation, said a key figure at Procter & Gamble (P&G).
"If the financial markets operated like the healthcare market does with data, you would have to call 100 people every day to find out how the market is doing," said Greg Simon, CEO of FasterCures.
As major pharmaceutical manufacturers introduce radiofrequency identification (RFID) tags into pharmaceutical packaging to prevent counterfeiting and diversion, some privacy advocates have begun to object that patient privacy and even safety could be compromised.